ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR Convergence 2022

Abstract Number: 1163

Proteomic Investigation to Identify Urinary Biomarker for Ankylosing Spondylitis

Ji-Hyun Lee1, Jeesoo Kim2, Sang-Hyon kim1, Jong‑Seo kim2 and Chang-Nam son1, 1Keimyung University, Dalseo-gu, Daegu, Republic of Korea, 2seoul national university, Seoul, Republic of Korea

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR Convergence 2022

Keywords: Ankylosing spondylitis (AS), Biomarkers, proteomics

Session Information

Date: Sunday, November 13, 2022

Title: Spondyloarthritis Including PsA – Basic Science Poster

Session Type: Poster Session C

Session Time: 1:00PM-3:00PM

Background/Purpose: Ankylosing spondylitis (AS) is a chronic inflammatory rheumatic disease that affects the spine and peripheral joints, and the exact etiology is still unknown. Diagnosis with urinary sample is a fascinate approach without patient’s pain due to its non-invasive nature. In this study, we performed proteomic analysis of AS urinary samples. Our aim is to discover novel diagnostic urinary biomarkers in the AS.

Methods: A total of 50 urine samples from 20 AS and each 10 controls [rheumatoid arthritis (RA), gout, healthy control (HC)] were collected. We collected AS and HC samples only from young males (< 50 years of age). Label-free quantitative proteomics were preformed and the resulting datasets were analyzed by MaxQuant (Ver.1.6.2.3) with Uniprot human database. Differentially expressed proteins were determined based on the fold change and p-value from LFQ(label-free quantitation) intensities log2(fold change >=1.5) and p-value< 0.05.

Results: From all urinary samples analyzed by liquid chromatography and tandem mass spectrometry (LC-MS/MS), we identified 1,975 proteins. Among them, we first found six proteins were differentially upregulated in AS patient group compared to the control group: cystatin-A(CSTA), collagen alpha-1 chain (COL14A1), alpha-amylase 1A(AMY1A), syndecan-1(SDC1), S100-A6(S100A6) and phosphoinositide-3-kinase-interacting protein 1(PIK3IP1) (Table 1). Interestingly, some of these proteins were previously observed as urinary biomarkers in other disease. For example, alpha-amylase 1A was highly expressed in the urine of prostate cancer, S100-A6 in the urine of upper gastrointestinal cancer, and PIK3IP1 in the urine of exertional rhabdomyolysis.

Conclusion: Diagnosing AS based on non-invasive manner still remains a challenge. We performed quantitative proteomic profiling of the respective urine samples from 4 diseases, i.e., AS, RA, gout and HC, and thereby identified six potential urinary biomarkers for AS. We will conduct molecular biological validation studies.

Supporting image 1

Table 1. List of proteins with increased levels in the Urine of ankylosing spondylitis patients vs other control groups.


Disclosures: J. Lee, None; J. Kim, None; S. kim, None; J. kim, None; C. son, None.

To cite this abstract in AMA style:

Lee J, Kim J, kim S, kim J, son C. Proteomic Investigation to Identify Urinary Biomarker for Ankylosing Spondylitis [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/proteomic-investigation-to-identify-urinary-biomarker-for-ankylosing-spondylitis/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/proteomic-investigation-to-identify-urinary-biomarker-for-ankylosing-spondylitis/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology